Dose-Adjusted Apixaban
A Clinical Trial of Dose-Adjusted Apixaban In CancerPatients with Thrombocytopenia and Venous Thromboembolism
Sponsors:
Beth Israel Deaconess Medical Center, USA
Design
Single arm prospective cohort study of dose-adjusted apixaban in 30 patients with active malignancy and acute VTE.
Participating Sites
Lead Network:
VENUS
Countries:
The Netherlands, USA,Lead Investigators
Mandy Lauw, MD PhD
Erasmus University Rotterdam, the Netherlands.
Rushad Patell, MD
Harvard University, USA.
Subscribe